We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study

    Background

    This study investigated the current status of the quality of life (QOL) of drug-resistant tuberculosis (DR-TB) patients in Nan**g, China,...

    He Wang, Jiayi Gu, ... Yan Song in BMC Pulmonary Medicine
    Article Open access 27 June 2024
  2. Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital

    Introduction

    In alignment with China’s national directive for improved drug management in anesthesiology, the Affiliated Hospital of Qingdao...

    **aomin **ng, Haijun Qu, ... Fanbo **g in Advances in Therapy
    Article 18 March 2024
  3. Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument

    Background

    With the progress of therapeutic drug monitoring (TDM) technology and the development of evidence-based medicine, many guidelines were...

    Zhan-Miao Yi, **nya Li, ... Rongsheng Zhao in Clinical Pharmacokinetics
    Article 25 July 2023
  4. A systematic review on reporting quality of economic evaluations for negotiated glucose-lowering drugs in China national reimbursement drug list

    Background

    This study aimed to examine the reporting quality of existing economic evaluations for negotiated glucose-lowering drugs (GLDs) included in...

    Shi-Yi Bao, Liu Liu, ... Ying-Yao Chen in BMC Health Services Research
    Article Open access 01 May 2024
  5. Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

    Background

    The Global Drug Facility (GDF) of the Stop TB Partnership was launched in 2001 with the goal of increasing access to quality-assured...

    Stefan Kohler, Jay Achar, ... Nicolas Paul in Globalization and Health
    Article Open access 25 June 2024
  6. Correlation between the number of patient-reported adverse events, adverse drug events, and quality of life in older patients: an observational study

    Background

    Previous studies on medication therapy management services, e.g. medication reconciliation and medication review, do not show consistent...

    Cathelijn J. Beerlage-Davids, Godelieve H. M. Ponjee, ... Fatma Karapinar-Çarkit in International Journal of Clinical Pharmacy
    Article 15 October 2022
  7. Health-related quality of life and influencing factors in drug addicts based on the scale QLICD-DA: a cross-sectional study

    Background

    Drug abuse has many negative effects not only on individuals but also on society. Nowadays, researchers pay a lot of attention to quality...

    Zilin Ma, Yuxi Liu, ... Ying Zhang in Health and Quality of Life Outcomes
    Article Open access 14 July 2022
  8. Consumer expectations, drug effects, price and purity of heroin and cocaine purchased at drug consumption rooms

    Background

    Drug consumption rooms offer heroin and cocaine consumers a secure and hygienic environment including medical and social guidance. Despite...

    Georges Dahm, Karin Roschel, ... Serge Schneider in Harm Reduction Journal
    Article Open access 04 August 2023
  9. The health-related quality of life of lung cancer patients with EGFR-TKI-related skin adverse drug reactions and its relationship with co** style and self-management

    Purpose

    The status and associated factors of the health-related quality of life of non-small-cell lung cancer (NSCLC) patients under targeted...

    Ruofei Du, **n Wang, ... Tao Wang in Supportive Care in Cancer
    Article 19 November 2022
  10. International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials

    In June 2021, the US Food and Drug Administration (FDA) released a draft guidance for industry on core patient-reported outcomes (PROs) and related...

    Keri J. S. Brady, John Devin Peipert, ... Jessica Roydhouse in Quality of Life Research
    Article Open access 23 May 2023
  11. Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization

    Due to cancer’s complex nature and variable response to therapy, precision oncology informed by omics sequence analysis has become the current...

    Patrick J. Lawrence, Benjamin Burns, **a Ning in npj Precision Oncology
    Article Open access 18 May 2024
  12. Anesthetic drug discovery with computer-aided drug design and machine learning

    Computer-aided drug design (CADD) has emerged as a highly effective and indispensable tool for streamlining the drug discovery process, leading to...

    **anggen Liu, Zhe Xue, ... Jiancheng Lv in Anesthesiology and Perioperative Science
    Article Open access 15 January 2024
  13. Impact and implications of national centralized drug procurement in China

    The national centralized drug procurement (NCDP) policy, known as the “4 + 7” policy in China, has transformed pharmaceutical procurement and access...

    Zhizhou Wang, Ke Wang, ... Lan Zhang in International Journal of Clinical Pharmacy
    Article 11 July 2024
  14. A drug free solution for improving the quality of life of fibromyalgia patients (Fibrepik): study protocol of a multicenter, randomized, controlled effectiveness trial

    Background

    Fibromyalgia is a form of chronic widespread pain that is defined as a syndrome of chronic symptoms of moderate to severe intensity,...

    Emilie Chipon, Jean-Luc Bosson, ... Caroline Maindet in Trials
    Article Open access 05 September 2022
  15. Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges

    Polypharmacy is commonly employed in clinical settings. The potential risks of drug–drug interactions (DDIs) can compromise efficacy and pose serious...

    Di Zhao, ** Huang, ... Yu He in Clinical Pharmacokinetics
    Article 18 June 2024
  16. Signal Detection and Assessment of Herb–Drug Interactions: Saudi Food and Drug Authority Experience

    Introduction

    Numerous investigations on herbal medicine that have been undertaken in the past several years demonstrate the general acceptance of its...

    Waad Alghamdi, Nouf Al-Fadel, ... Fawaz Alharbi in Drugs - Real World Outcomes
    Article Open access 19 October 2023
  17. Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques

    Introduction

    Concerns have been raised over the quality of drug safety information, particularly data completeness, collected through spontaneous...

    Siun Kim, Taegwan Kang, ... Howard Lee in Drug Safety
    Article Open access 17 June 2023
  18. Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport

    Background

    Emulsomes are a type of lipid-based nanoparticle that consists of a solid lipid core surrounded by a phospholipid bilayer and have shown...

    Shivam Singh, Kunal Khurana, ... Indu Singh in Future Journal of Pharmaceutical Sciences
    Article Open access 05 September 2023
  19. Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease

    Background

    Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge...

    John W Peabody, Divya Ganesan, ... Rebecca Heltsley in BMC Primary Care
    Article Open access 15 April 2023
  20. Impact of a drug-related patient-reported outcome measure on drug-related problem identification, physicians’ acceptance, and clinical and quality of life outcomes: a randomized controlled trial

    Background : Data are scarce regarding the usefulness of a pharmaceutical therapy-related quality of life measure including the Patient-Reported...

    Phantipa Sakthong, Piyaporn Jaisue in International Journal of Clinical Pharmacy
    Article 16 November 2021
Did you find what you were looking for? Share feedback.